Landos Biopharma Inc. Made Big Gain
Mon, Dec 19, 2022 at 07:02 PM
Landos Biopharma Inc. (LABP:NASDAQ) shot up at $0.41, representing a gain of 56.3%. On Mon, Dec 19, 2022, LABP:NASDAQ touched a New 2-Week High of $0.41. From Mon, Dec 05, 2022, the stock recorded 60.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Dec 15, 2022 at $0.47 with a volume of 2M+.
About Landos Biopharma Inc. (LABP:NASDAQ)
Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases.
Top 10 Gainers:
- Starry Group Holdings Inc. Class A (STRY:NYSE), 581.82%
- Madrigal Pharmaceuticals, Inc. (MDGL:NASDAQ), 268.07%
- Axcella Health Inc. (AXLA:NASDAQ), 165.27%
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 103.86%
- Qumu Corporation (QUMU:NASDAQ), 100%
- Viking Therapeutics, Inc. (VKTX:NASDAQ), 73.88%
- Camber Energy, Inc. (CEI:NYSEMKT), 72.9%
- Landos Biopharma Inc. (LABP:NASDAQ), 56.31%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 49.26%